These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4421563)

  • 1. Sensitisation of lymphocytes in vitro against human melanoma-associated antigens.
    Golub SH; Morton DL
    Nature; 1974 Sep; 251(5471):161-3. PubMed ID: 4421563
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of human malignant melanoma cell lines. VI. Inhibition of 3H-thymidine uptake by normal stimulated lymphocytes.
    Lui VK; Dent PB; Liao SK
    Oncology; 1977; 34(6):251-4. PubMed ID: 593653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of lymphocytes in vitro to reactions against cultured Burkitt's lymphoma cells.
    Golub SH; Hewetson JF; Svedmyr AJ; Klein G; Singh S
    Natl Cancer Inst Monogr; 1973 Jun; 37():25-32. PubMed ID: 4713782
    [No Abstract]   [Full Text] [Related]  

  • 4. Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cells.
    Lejeune FJ
    Yale J Biol Med; 1973 Dec; 46(5):368-83. PubMed ID: 4205114
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of viable frozen lymphocytes for studies in human tumor immunology.
    Golub SH; Sulit HL; Morton DL
    Transplantation; 1975 Mar; 19(3):195-202. PubMed ID: 124484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic lymphocytes against human tumor cells in vitro by various soluble microbial extracts.
    Sharma B; Brunda MJ; Minden P
    J Natl Cancer Inst; 1979 Aug; 63(2):341-6. PubMed ID: 222929
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte stimulation in vitro: generation of cytotoxic effector lymphocytes using subcellular fractions of a lymphoid cell line.
    Corley RB; Dawson JR; Amos DB
    Cell Immunol; 1975 Mar; 16(1):92-105. PubMed ID: 123177
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for immune reactivity against neoplasms.
    McKhann CF; Jagarlamoody SM
    Transplant Rev; 1971; 7():55-77. PubMed ID: 4112673
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cells.
    Gillespie GY; Barth RF
    Cancer; 1978 Jun; 41(6):2174-82. PubMed ID: 350374
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. II. Sensitization against melanoma-associated antigens.
    Golub SH
    Cell Immunol; 1977 Feb; 28(2):379-89. PubMed ID: 849604
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro lymphocyte reactivity to soluble tumor extracts in Sinclair melanoma swine.
    Aultman MD; Hook RR
    Int J Cancer; 1979 Nov; 24(5):673-8. PubMed ID: 528082
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
    Jehn UW; Nathanson L; Schwartz RS; Skinner M
    N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response.
    Chess L; Bock GN; Ungaro PC; Buchholz DH; Mardiney MR
    J Natl Cancer Inst; 1973 Jul; 51(1):57-65. PubMed ID: 4720886
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
    Vanwijck R; Bouillenne C; Malek-Mansour S
    Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human malignant melanoma cells: morphological and immunological variations.
    Hakim AA
    Neoplasma; 1977; 24(1):81-99. PubMed ID: 840339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition and destruction of target cells by tumoricidal macrophages.
    Fidler IJ
    Isr J Med Sci; 1978 Jan; 14(1):177-91. PubMed ID: 204610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.